4F-PPP

WARNING: No human experience reports, pharmacological studies, or toxicological data exist for 4F-PPP. This compound has only been identified as an analytical reference standard. The parent compound α-PPP shows reinforcing effects in animal models. Related fluorinated pyrrolidinophenones have been implicated in fatalities. Without any established safety profile, this substance should be considered extremely high-risk.

Also known as: 4'-fluoro-α-ppp, Para‑fluoro‑α‑PPP, PFPPP

Classification

Chemical: Cathinone
Psychoactive: Stimulant
Tag: Pyrrolidine
Tag: Pyrrolidinophenone
Tag: Research-Chemical

Effects

Stimulation
Physical Energy
Loss Of Appetite
Increased Heart Rate
Vasoconstriction Cold Extremities
Teeth Grinding
Euphoria
Talkativeness
Sociability Enhancement
Increased Focus
Anxiety
Paranoia
Light Sensitivity
Appetite Suppression
Increased Libido
Disinhibition
Tactile Enhancement
Dehydration

Routes of Administration

Oral

Dosage

Heavy: 70+ mg
Light: 15–30 mg
Common: 30–50 mg
Strong: 50–70 mg
Threshold: 5–10 mg

Duration

Onset: 0.33-1 h
Peak: 0.5-2 h
Offset: 2-4 h
After Effects: 4-18 h
Total Duration: 3-6 h

Insufflated

Dosage

Heavy: 45+ mg
Light: 5–15 mg
Common: 15–30 mg
Strong: 30–45 mg
Threshold: 3–5 mg

Duration

Onset: 0.08-0.25 h
Peak: 0.25-1 h
Offset: 1-2 h
After Effects: 2-12 h
Total Duration: 2.5-5 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

dose.wiki

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu